A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）

NCT02203422 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No eligible patient was enrolled.

Conditions

Immune Thrombocytopenia

Interventions

DRUG: Cyclosporin A
DRUG: rhTPO

Sponsor

Shandong University